Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Leukemia 75Myelodysplastic Syndromes 72Leukemia, Lymphocytic, Chronic, B-Cell 67Lymphoma, Non-Hodgkin 66Multiple Myeloma 58Hodgkin Disease 54Lymphoma, Mantle-Cell 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 49Leukemia, Myeloid, Chronic-Phase 48Lymphoma 44Lymphoma, B-Cell, Marginal Zone 43Burkitt Lymphoma 43Myeloproliferative Disorders 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelomonocytic, Chronic 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 37Anemia, Refractory, with Excess of Blasts 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Dendritic Cell Sarcoma, Interdigitating 30Blast Crisis 30Recurrence 29Graft vs Host Disease 29Primary Myelofibrosis 25Waldenstrom Macroglobulinemia 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 22

Interventions

thymoglobulin 1Prone Position 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1Acetazolamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neural Tube Defects × Cyclosporine × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡